Inherited metabolic disorders Flashcards
Name the 4 types of glycogen storage disease
Von Gierke’s disease (type I)
Pompe’s disease (type II)
Cori disease (type III)
McArdle’s disease (type V)
Glucose-6-phosphatase deficiency
Hepatic glycogen accumulation.
Key features include hypoglycaemia, lactic acidosis, hepatomegaly
Von Gierke’s disease (type I)
Lysosomal alpha-1,4-glucosidase deficiency
Cardiac, hepatic and muscle glycogen accumulation.
Key features include cardiomegaly
Pompe’s disease (type II)
Alpha-1,6-glucosidase (debranching enzyme) deficiency Hepatic, cardiac glycogen accumulation.
Key features include muscle hypotonia
Cori disease (type III)
Glycogen phosphorylase (myophosphorylase) deficiency
Skeletal muscle glycogen accumulation.
Key features include myalgia, myoglobinuria with exercise
McArdle’s disease (type V)
Give examples of Lysosomal storage disease
Gaucher’s disease
Tay-Sachs disease
Niemann-Pick disease
Fabry disease
Krabbe’s disease
Metachromatic leukodystrophy
Beta-glucocerebrosidase defect
Most common lipid storage disorder resulting in accumulation of glucocerebrosidase in the brain, liver and spleen.
Key features include hepatosplenomegaly, aseptic necrosis of the femur
Gaucher’s disease
Hexosaminidase A defect
Accumulation of GM2 ganglioside within lysosomes.
Key features include developmental delay, cherry red spot on the macula, liver and spleen normal size
Tay-Sachs
Sphingomyelinase defect
Key features include hepatosplenomegaly, cherry red spot on the macula
Niemann-Pick disease
Alpha-galactosidase-A defect
Accumulation of ceramide trihexoside.
Key features include angiokeratomas, peripheral neuropathy of extemeties, renal failure
Fabry disease
Galactocerebrosidase defect
Key features include peripheral neuropathy, optic atrophy, globoid cells
Krabbe’s disease
Arylsulfatase A defect
Demyelination of the central and peripheral nervous system
Metachromatic leukodystrophy
Mucopolysaccharidoses
Hurler Syndrome (Type 1)
Hunter Syndrome (type 2)
Alpha-1-iduronidase defect
Accumulation of glycosaminoglycans (heparan and dermatan sulfate).
Key features include gargoylism, hepatosplenomegaly, corneal clouding
hurler Syndrome (Type 1)
Iduronate sulfatase defect
Accumulation of glycosaminoglycans (heparan and dermatan sulfate).
Key features include coarse facial features, behavioural problems/learning difficulties short stature, no corneal clouding
Hunter Syndrome (Type 2)